Bourgeon Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $266K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $34.4K | Buy |
|
|||||
|
2023
Q3 | $2.27K | Hold |
|
|||||
|
2023
Q2 | $2.81K | Sell |
|
|||||
|
2023
Q1 | $92.7K | Buy |
|
|||||
|
2022
Q4 | $20.3K | Hold |
|
|||||
|
2022
Q3 | $33K | Hold |
|
|||||
|
2022
Q2 | $30K | Sell |
|
|||||
|
2022
Q1 | $113K | Buy |
|
|||||
|
2021
Q4 | $80K | Buy |
|
|||||
|
2021
Q3 | $62K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $15K | Buy |
|